Delivery Order SPE2DB22D2206-SPE2DB25FHS21
- Not listed
- The Defense Logistics Agency awarded a $23,660 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors. This competitive, firm fixed-price delivery order is scheduled for completion by October 10, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors valued at $11,830.00. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to complete by September 18, 2025, with performance executed from AmerisourceBergen's Conshohocken, Pennsylvania headquarters. This delivery order...
- The Defense Logistics Agency awarded a $11.83K delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body injector units. The contract is unset-aside and competitively awarded on a firm fixed-price basis, with performance originating from the company's Conshohocken, Pennsylvania facility and scheduled completion by October 8, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $11,830.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body injectors, with an ultimate completion date of September 9, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,830 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors. The contract, which carries an ultimate completion date of September 29, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors valued at $11,830.00 under a firm fixed price contract. The order, which is expected to be completed by September 9, 2025, will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without a set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $11,830 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body injector units on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a prescription biologic medication used to treat autoimmune conditions, and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $11,830 on September 8, 2025, for the supply of SKYRIZI 180 mg/1.2 ml on-body injectors. This firm fixed-price delivery order, with completion expected by September 29, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a $38,306.42 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations for federal...
- The Defense Logistics Agency awarded a $25,209.26 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body injectors on April 29, 2025, with a completion date of May 20, 2025. This firm fixed price, non-set-aside contract was issued under a competitive procurement process and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic treatment used for dermatological conditions, representing part of the company's...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHS21Delivery Order
The Defense Logistics Agency awarded a $35,490 delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body auto-injector units. This is a firm fixed price, non-competitive set-aside delivery order with an ultimate completion date of July 22, 2025, to be fulfilled from the vendor's operations in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier of medical products to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's substantial IDC vehicle with DLA enables comprehensive pharmaceutical support across therapeutic domains, including specialty medications, biologics, vaccines, and medical devices. This specific delivery order for SKYRIZI, a specialty pharmaceutical used in dermatological treatment, demonstrates the vendor's role in supplying specialized healthcare commodities to support military and federal medical programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.5k | 6/30/25 |